TP53 and neoplasm: However, its function is almost always compromised in tumor cells through gene mutation, deletion, epigenetic silencing or protein degradation.1 With the evolvement of the cognition on this protein, a plethora of evidence confirm that mutant p53 proteins not only lose their tumor-suppressive function and acquire dominant-negative activities, but also gain new oncogenic properties that are independent of wild-type p53.